Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
IEEE Journal of Translational Engineering in Health and Medicine|July 22, 2022
Smartphone-Based Colorimetric Analysis of Urine Test Strips for At-Home Prenatal CareMadeleine Flaucher, Michael Nissen, Katharina M Jaeger, et al.Acta Crystallographica. Section D, Structural Biology|February 9, 2021
Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162Dieter Moosmayer, André Hilpmann, Jutta Hoffmann, et al.ACS Medicinal Chemistry Letters|November 22, 2019
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell KillingTimothy A Lewis, Luc de Waal, Xiaoyun Wu, et al.Chemmedchem|April 3, 2020
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS<sup>G12C</sup>Jérémie Mortier, Anders Friberg, Volker Badock, et al.Leukemia|April 4, 2019
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignanciesSven Christian, Claudia Merz, Laura Evans, et al.Journal of Medicinal Chemistry|February 21, 2023
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21Fabian Göricke, Victoria Vu, Leanna Smith, et al.Bioorganic & Medicinal Chemistry Letters|August 2, 2011
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationshipsSteve Wenglowsky, Kateri A Ahrendt, Alex J Buckmelter, et al.Neuro-Oncology Advances|August 21, 2024
Velcrin molecular glues induce apoptosis in glioblastomas with high <i>PDE3A</i> and <i>SLFN12</i> expressionElisa Aquilanti, Silvia Goldoni, Andrew Baker, et al.Journal of Medicinal Chemistry|October 25, 2024
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran <i>In Vivo</i>-Active KAT6AB InhibitorAntonius Ter Laak, Roman C Hillig, Steven J Ferrara, et al.SLAS Discovery : Advancing Life Sciences R & D|June 22, 2021
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput ScreeningStefan Gradl, Holger Steuber, Joerg Weiske, et al.Pageof 3